Skip to content

Investigation of the Therapeutic Effects of Hyperbaric Oxygen on Vascular Cognitive Impairment and the Underlying Mechanisms of Mitochondrial Remodeling

Investigation of the Therapeutic Effects of Hyperbaric Oxygen on Vascular Cognitive Impairment and the Underlying Mechanisms of Mitochondrial Remodeling

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115614
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VCI (Vascular Cognitive Impairment)

Interventions

Sponsors

Shanghai Geriatric Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Aged 50 to 85 years, regardless of gender; 2.Meet the clinical and neuroimaging diagnostic criteria for VCI, with evidence of cognitive decline in one or more cognitive domains (such as executive function, processing speed, attention, memory, language, or visuospatial ability) confirmed through clinical assessment and neuropsychological testing; 3.Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Medical history, clinical, and neuroimaging evidence suggests other potential etiologies for cognitive impairment (such as Alzheimer’s disease, Lewy body dementia, frontotemporal degeneration, normal pressure hydrocephalus, hypothyroidism, vitamin deficiency, severe depression, drug side effects, chronic infections, poisoning, etc.); 2.Presence of untreated pneumothorax, severe respiratory infection or obstructive disease, decompensated heart failure, severe arrhythmia, active bleeding or severe coagulation disorder, uncontrolled epilepsy or high fever, or recent use of chemotherapeutic agents such as bleomycin, cisplatin, or doxorubicin.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment (MoCA) Score;

Secondary

MeasureTime frame
Mitochondrial Metabolism-related Indicators;OTCA;ADL;

Countries

China

Contacts

Public ContactWeifeng Peng

Shanghai Geriatric Medical Center

peng.weifeng@zs-hospital.sh.cn+86 21 5137 1990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026